Risperdal Consta

DRUG6 trials

Conditions

Antipsychotic AgentsBipolar DisorderMental DisordersPhysiological Effects of DrugsPsychotropic DrugsSchizoaffective DisorderSchizophreniaTherapeutic Uses

Phase 1

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

CompletedNCT02411526

Zogenix, Inc.Schizoaffective Disorder, Schizophrenia

Start: 2015-02-28End: 2015-09-30Updated: 2022-10-31

Phase 3

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

CompletedNCT00094926

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Bipolar Disorder

Start: 2004-05-31End: 2007-02-28Updated: 2011-05-19

A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

CompletedNCT00132678

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Bipolar Disorder

Start: 2005-02-28End: 2007-12-31Updated: 2013-07-29

Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia

CompletedNCT00589914

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Schizophrenia

Start: 2007-03-31End: 2009-06-30Updated: 2014-06-24

Phase 4

Risperdal Consta and Health Care Utilization in Patients With Schizophrenia

CompletedNCT00313391

Emory UniversitySchizoaffective Disorder, Schizophrenia

Start: 2005-12-31Updated: 2014-09-25

Unknown Phase

A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

CompletedNCT00294008

Janssen Korea, Ltd., KoreaAntipsychotic Agents, Mental Disorders, Physiological Effects of Drugs +4

Start: 2004-12-31End: 2009-06-30Updated: 2014-04-03

Related Papers

Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia.

2014-05-017 citations

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics.

2013-03-0519 citations